Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Reassessing the role of histaminergic tuberomammillary neurons in arousal control.

Venner A, Mochizuki T, De Luca R, Anaclet C, Scammell TE, Saper CB, Arrigoni E, Fuller PM.

J Neurosci. 2019 Sep 23. pii: 1032-19. doi: 10.1523/JNEUROSCI.1032-19.2019. [Epub ahead of print]

PMID:
31548232
2.

Differential Role of Pontomedullary Glutamatergic Neuronal Populations in Sleep-Wake Control.

Erickson ETM, Ferrari LL, Gompf HS, Anaclet C.

Front Neurosci. 2019 Jul 30;13:755. doi: 10.3389/fnins.2019.00755. eCollection 2019.

3.

Newly identified sleep-wake and circadian circuits as potential therapeutic targets.

Venner A, Todd WD, Fraigne J, Bowrey H, Eban-Rothschild A, Kaur S, Anaclet C.

Sleep. 2019 May 1;42(5). pii: zsz023. doi: 10.1093/sleep/zsz023.

PMID:
30722061
4.

Genetic Activation, Inactivation, and Deletion Reveal a Limited And Nuanced Role for Somatostatin-Containing Basal Forebrain Neurons in Behavioral State Control.

Anaclet C, De Luca R, Venner A, Malyshevskaya O, Lazarus M, Arrigoni E, Fuller PM.

J Neurosci. 2018 May 30;38(22):5168-5181. doi: 10.1523/JNEUROSCI.2955-17.2018. Epub 2018 May 7.

5.

Functionally Complete Excision of Conditional Alleles in the Mouse Suprachiasmatic Nucleus by Vgat-ires-Cre.

Weaver DR, van der Vinne V, Giannaris EL, Vajtay TJ, Holloway KL, Anaclet C.

J Biol Rhythms. 2018 Apr;33(2):179-191. doi: 10.1177/0748730418757006.

6.

Activation of the GABAergic Parafacial Zone Maintains Sleep and Counteracts the Wake-Promoting Action of the Psychostimulants Armodafinil and Caffeine.

Anaclet C, Griffith K, Fuller PM.

Neuropsychopharmacology. 2018 Jan;43(2):415-425. doi: 10.1038/npp.2017.152. Epub 2017 Jul 19.

7.

Brainstem regulation of slow-wave-sleep.

Anaclet C, Fuller PM.

Curr Opin Neurobiol. 2017 Jun;44:139-143. doi: 10.1016/j.conb.2017.04.004. Epub 2017 May 10. Review.

8.

A Novel Population of Wake-Promoting GABAergic Neurons in the Ventral Lateral Hypothalamus.

Venner A, Anaclet C, Broadhurst RY, Saper CB, Fuller PM.

Curr Biol. 2016 Aug 22;26(16):2137-43. doi: 10.1016/j.cub.2016.05.078. Epub 2016 Jul 14.

9.

Basal forebrain control of wakefulness and cortical rhythms.

Anaclet C, Pedersen NP, Ferrari LL, Venner A, Bass CE, Arrigoni E, Fuller PM.

Nat Commun. 2015 Nov 3;6:8744. doi: 10.1038/ncomms9744.

10.

The GABAergic parafacial zone is a medullary slow wave sleep-promoting center.

Anaclet C, Ferrari L, Arrigoni E, Bass CE, Saper CB, Lu J, Fuller PM.

Nat Neurosci. 2014 Sep;17(9):1217-24. doi: 10.1038/nn.3789. Epub 2014 Aug 17. Erratum in: Nat Neurosci. 2014 Dec;17(12):1841.

11.

Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice.

Gondard E, Anaclet C, Akaoka H, Guo RX, Zhang M, Buda C, Franco P, Kotani H, Lin JS.

Neuropsychopharmacology. 2013 May;38(6):1015-31. doi: 10.1038/npp.2012.266. Epub 2013 Jan 2.

12.

Identification and characterization of a sleep-active cell group in the rostral medullary brainstem.

Anaclet C, Lin JS, Vetrivelan R, Krenzer M, Vong L, Fuller PM, Lu J.

J Neurosci. 2012 Dec 12;32(50):17970-6. doi: 10.1523/JNEUROSCI.0620-12.2012.

13.

Effects of GF-015535-00, a novel α1 GABA A receptor ligand, on the sleep-wake cycle in mice, with reference to zolpidem.

Anaclet C, Zhang M, Zhao C, Buda C, Seugnet L, Lin JS.

Sleep. 2012 Jan 1;35(1):103-11. doi: 10.5665/sleep.1596.

14.

Brainstem and spinal cord circuitry regulating REM sleep and muscle atonia.

Krenzer M, Anaclet C, Vetrivelan R, Wang N, Vong L, Lowell BB, Fuller PM, Lu J.

PLoS One. 2011;6(10):e24998. doi: 10.1371/journal.pone.0024998. Epub 2011 Oct 17.

15.

The waking brain: an update.

Lin JS, Anaclet C, Sergeeva OA, Haas HL.

Cell Mol Life Sci. 2011 Aug;68(15):2499-512. doi: 10.1007/s00018-011-0631-8. Epub 2011 Feb 13. Review.

16.

Sleep-waking discharge of ventral tuberomammillary neurons in wild-type and histidine decarboxylase knock-out mice.

Sakai K, Takahashi K, Anaclet C, Lin JS.

Front Behav Neurosci. 2010 Oct 20;4:53. doi: 10.3389/fnbeh.2010.00053. eCollection 2010.

17.

Brainstem circuitry regulating phasic activation of trigeminal motoneurons during REM sleep.

Anaclet C, Pedersen NP, Fuller PM, Lu J.

PLoS One. 2010 Jan 20;5(1):e8788. doi: 10.1371/journal.pone.0008788.

18.

Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models.

Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, Akaoka H, Sergeeva OA, Yanagisawa M, Ohtsu H, Franco P, Haas HL, Lin JS.

J Neurosci. 2009 Nov 18;29(46):14423-38. doi: 10.1523/JNEUROSCI.2604-09.2009.

19.

Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.

Guo RX, Anaclet C, Roberts JC, Parmentier R, Zhang M, Guidon G, Buda C, Sastre JP, Feng JQ, Franco P, Brown SH, Upton N, Medhurst AD, Lin JS.

Br J Pharmacol. 2009 May;157(1):104-17. doi: 10.1111/j.1476-5381.2009.00205.x.

20.

An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients.

Lin JS, Dauvilliers Y, Arnulf I, Bastuji H, Anaclet C, Parmentier R, Kocher L, Yanagisawa M, Lehert P, Ligneau X, Perrin D, Robert P, Roux M, Lecomte JM, Schwartz JC.

Neurobiol Dis. 2008 Apr;30(1):74-83. doi: 10.1016/j.nbd.2007.12.003. Epub 2007 Dec 27.

PMID:
18295497
21.

Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649.

Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, Lin JS, Burban A, Arrang JM, Schwartz JC.

Biochem Pharmacol. 2007 Apr 15;73(8):1215-24. Epub 2007 Jan 21.

PMID:
17343831
22.

The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.

Parmentier R, Anaclet C, Guhennec C, Brousseau E, Bricout D, Giboulot T, Bozyczko-Coyne D, Spiegel K, Ohtsu H, Williams M, Lin JS.

Biochem Pharmacol. 2007 Apr 15;73(8):1157-71. Epub 2007 Jan 7.

PMID:
17288995
23.

The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward.

Brabant C, Quertemont E, Anaclet C, Lin JS, Ohtsu H, Tirelli E.

Psychopharmacology (Berl). 2007 Feb;190(2):251-63. Epub 2006 Oct 28.

PMID:
17072589
24.

BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology.

Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte JM, Parmentier R, Anaclet C, Lin JS, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang JM, Ganellin CR, Stark H, Schunack W, Schwartz JC.

J Pharmacol Exp Ther. 2007 Jan;320(1):365-75. Epub 2006 Sep 27.

PMID:
17005916

Supplemental Content

Support Center